Topic: drug discovery
-
Chan Zuckerberg's rBio Trains AI with Virtual Cells, Skips Lab Work
The Chan Zuckerberg Initiative has developed rBio, an AI system that uses virtual simulations to model cellular biology, potentially saving significant time and costs in biomedical research. rBio employs a technique called soft verification and reinforcement learning to handle biological uncertai...
Read More » -
AI-Designed Viruses Now Deployed to Combat Bacterial Infections
AI is being used to design bacteriophages that precisely target and destroy antibiotic-resistant bacteria, offering a new approach to combating infections. This AI-driven method accelerates biological discovery by rapidly generating functional viral designs, as demonstrated by successful lab resu...
Read More » -
AI Agents: Match Them to Processes, Not the Other Way Around
AI agents are most effective when integrated into existing workflows to enhance efficiency and innovation, as demonstrated by companies like Block and GSK, rather than forcing employees to adapt to new technology. Successful implementation relies on process alignment and human-centric design, whe...
Read More » -
IBM and AMD Bet on Quantum Computing After AI Setback
IBM and AMD have partnered to develop next-generation computing architectures that combine IBM's quantum systems with AMD's AI-optimized processors. The collaboration aims to create a scalable, open-source quantum computing framework for applications in drug discovery, materials science, and logi...
Read More » -
Hausi Müller: Pioneering Quantum Computing Breakthroughs
Quantum computing has transformative potential across industries like healthcare and finance, with experts like Hausi Müller bridging theory and real-world applications. Mastering quantum computing requires skills in linear algebra, qubits, programming (e.g., Python, Qiskit), and error correction...
Read More »
